• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. O-0028 Bevacizumab Continuation Versus No Continuation After First-Line Chemo-Bevacizumab Therapy in Patients with Metastatic Colorectal Cancer: a Phase 3 Non-Inferiority Trial
 

O-0028 Bevacizumab Continuation Versus No Continuation After First-Line Chemo-Bevacizumab Therapy in Patients with Metastatic Colorectal Cancer: a Phase 3 Non-Inferiority Trial

Options
  • Details
  • Files
BORIS DOI
10.7892/boris.115252
Publisher DOI
10.1093/annonc/mdt201.28
Date of Publication
2013
Publication Type
Conference Item
Subject(s)
600 Technology > 610 Medicine & health
Language(s)
en
Contributor(s)
Koeberle, Dieter
Betticher, Daniel
Von Moos, Roger
Dietrich, Daniel
Brauchli, Peter
Baertschi, Daniela
Matter-Walstra, Klazien
Winterhalder, Ralph
Borner, Markus
Anchisi, Sandro
Moosmann, Peter
Kollár, Attila
Universitätsklinik für Medizinische Onkologie
Saletti, Piercarlo
Roth, Arnaud
Frueh, Martin
Kueng, Marc
Popescu, Razvan
Schacher, Sabina
Hess, Viviane
Herrmann, Richard
Additional Credits
Universitätsklinik für Medizinische Onkologie
Series
Annals of oncology
Publisher
Oxford University Press
ISSN
0923-7534
Title of Event
ESMO 15th World Congress on Gastrointestinal Cancer
Access(Rights)
open.access
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: dd892c [ 9.04. 8:30]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo